Cholinergics Flashcards
Hemicholinium receptor/mechnism
Blocks choline transporter CHT1 preventing uptake and synthesis of acetylcholine
Used for research
Vesamicol receptor/mechanism
Blocks the vesicular ACh-H+ antiporter VAChT preventing storage of ACh
Used for research
Botulinum Toxin receptor/mechanism
Prevents synaptic vesicle fusion inhibiting ACh release (synaptobrevin)
Used in local injection; conditions with excess muscle tone (blepharospasm); wrinkles, HA and pain
Neuromuscular blockers drugs
Tubocurarine and Succinylcholine
Tubocurarine receptor/mechanism
Non depolarizing
Binds to Nm->competitive inhibition
Prevents depolarization
Tubocurarine indication/effect
Anesthesia->muscle weakness and flaccid paralysis
Action can be overcome by AChE inhibitors such as neostigmine or edrophonium
Tubocurarine PK
Minimal oral absorption so need to be IV
Poor membrane penetration
Doesn’t cross BBB
Tubocurarine adverse
May cause histamine release
May bind M receptors
Succinylcholine receptor/mechanism
Depolarizing
Activates Nm causing depolarization -> transient disorganized contraction -> desensitization followed by flaccid paralysis
Succinylcholine indication/effect
Useful for ET intubation
Electroconvulsive therapy
Succinylcholine PK
continuous IV infusion
Rapid hydrolysis by plasma cholinesterase
Rapid onset (1m) and brief duration (5-10m)
Not metabolized effectively at the synapse
Succinylcholine adverse
Malignant hyperthermia an autosomal dominant disorder -> excess release of calcium from the SR; usually when combined with a halogenated anesthetic (Tx dantrolene)
Mecamylamine, Trimethaphan, Hexamethonium receptor/mechanism
Antagonize nicotinic receptors in both parasympathetic and sympathetic autonomic ganglia
Mecamylamine, Trimethaphan, Hexamethonium effects
Arterioles and veins are under predominant sympathetic control (adrenergic) -> dilation, hypotension, etc alpha 1
Block parasympathetics at the heart, iris and ciliaris muscle -> tachycardia, mydriasis, and cycloplegia (far vision)
GI, urinary bladder and salivary gland lose parasympathetics -> reduced motility, secretions; urinary retention, xerostomia (dry mouth)
Sweat glands lose sympathetics -> anhydrosis
Mecamylamine, Trimethaphan, Hexamethonium adverse
Vasodilation Venodilation Hypotension Tachycardia Mydriasis Decreased GI/urinary motility Xerostomia Anhydrosis
Mecamylamine, Trimethaphan, Hexamethonium other
Historically used to treat HTN, but have been replaced due to many undesirable effect
Dirty drugs
Pralidoxime effect
Regenerate cholinesterase after organophosphate poisoning (before aging)
Pralidoxime indication
not used for carbamate poisoning which is reversible and short lived
Pralidoxime other
Positively charged; it does not enter the CNS -> not effect on central sx
Tolterodine effect
Tertiary amine
Relaxes smooth muscle
Tolterodine indication
overactive bladder
Muscarinic antagonists
Atropine Scopolamine Ipratropium and Tiotropium Homatropine, Cyclopentolate, Tropicamide Benztropine, Trihexyphenidyl Glycopyrrolate Tolterodine
Glycopyrrolate indication
Oral: inhibition of GI motility
Parenteral: prevent bradycardia during surgery
Benztropine and Trihexyphenidyl Effects
Restore balance of input after loss of dopaminergic neurons in the nigrostriatal pathway
Benztropine and Trihexyphenidyl Indication
Parkinsonism Extrapyramidal effects ( i.e. drug induced movement disorders) of antipsychotic drugs (D2)
Benztropine and Trihexyphenidyl PK
tertiary amines are able to enter the CNS
Homatropine, Cyclopentolate, Tropicamide effects
Mydriasis and cycloplegia - preferred over atropine because of shorter duration of action
Homatropine, Cyclopentolate, Tropicamide PK
tertiary amines are able to enter the CNS
Ipratropium, Tiotropium effects
Bronchodilation (M3)
Ipratropium, Tiotropium indication
Inhalation Tx of *COPD and adjuvant therapy in asthma
Scopolamine effects/indication
DOC for motion sickness
Blocks short term memory (anesthetic procedures)
Scopolamine other
Belladonna Alkaloids-Tertiary amines
Greater and longer duration of action in the CNS than atropine
Atropine effects
Eye: mydriasis, unreactive to light, cycloplegia (paralysis of ciliaris muscle causing loss of accommodation and adaptation)
GI: antispasmodic; decreases motility (HCl production not affected)
Urinary: decreases hypermotility
CVS: low dose -> bradycardia (presynaptic M2)
moderate to high dose-> tachycardia (atrial M2)
Secretions from salivary, sweat and lacrimal glands are blocked (may increase body temperature)
Atropine indication
Antisialagogue prior to surgery decreases respiratory secretions
Increased HR or Decrease AV block due to excessive vagal tone
OD of cholinergic drugs (farmer spraying parathion)
Death cap mushroom poisoning
Alleviate the muscarinic side effects of AChE drugs
Atropine PK
readily absorbed, partially metabolized by the liver, eliminated primarily in the urine
Muscarinic antagonists contraindications/adverse effects
“Atropine flush” due to cutaneous vasodilation (especially in upper body)
Anti-PS ->dry mouth, blurred vision, sandy eyes, tachycardia, constipation
CNS: restlessness, confusion, hallucinations, delirium, depression -> shock and death
Elderly patients with angle closure glaucoma -> exacerbation and blindness
Use with caution in patients with BPH ->decrease detrusor contraction can cause urinary retention
Low levels may cause bradycardia and sedation
High levels may cause tachycardia and CNS hyper excitation (delirium, hallucinations, and seizures)
AChE Inhibitor drugs
Edrophonium (Tensilon) Physostigmine Neostigmine Pyridostigmine Echothiophate (obsolete) Malathion, Parathion Tabun, Sarin, Soman Tacrine, Donepezil, Rivastigmine, Galantamine
Tacrine, Donepezil, Rivastigmine, Galantamine indication
Orally used
Alzheimer’s disease
Tabun, Sarin, Soman mechanism
Phosphorylate active site (extremely stable)
Ageing-strengthening of the bond making it much more difficult to reverse
Malathion, Parathion mechanism
Phosphorylate active site (extremely stable)
Ageing-strengthening of the bond making it much more difficult to reverse
Echothiophate mechanism
Phosphorylate active site (extremely stable)
Ageing-strengthening of the bond making it much more difficult to reverse
Echothiphate indication
Chronic angle glaucoma
NOT liposoluble-> doesn’t enter CNS
Malathion, Parathion effects
Activated by conversion to oxygen analogs in the body
Malathion, Parathion indications
insecticides (farmer spraying his field…)
Malathion, Parathion PK
Fully distributed (including CNS)
Malathion, parathion adverse
Organophosphate overdose treated with atropine or Pralidoxime have to give before ageing
CNS toxicity
Tabun, Sarin, Soman adverse
Organophosphate overdose treated with atropine or Pralidoxime have to give before ageing
CNS toxicity
Tabun, Sarin, Soman effects
Nerve agents - most potent synthetic toxic agents known
Used for terrorism
Pyridostigmine indication
Treatment of Myasthenia gravis (most common)
Pyridostigmine adverse
CNS toxicity
Neostigmine mechnism
Covalent bond with AChE and ButyrylChE
Pyridostigmine mechanism
Covalent bond with AChE and ButyrylChE
Physostigmine mechanism
Covalent bond with AChE and ButyrylChE
Physostigmine chemical
carbamate - tertiary amine
Crosses BBB
Neostigmine and Pyridostigmine chemical
Carbamates - QAC - does not enter CNS
Edrophonium (Tensilon) chemical
simple alcohol QAC
Edrophonium (Tensilon) mechanism
Reversible binding to active site of AChE and butyrylcholinesterase
Neostigmine indications
Reversal of NMJ block produced by non depolarizing muscular blockers i.e. tubocurarine
Second line treatment for myasthenia gravis
Does not enter the CNS
Prevention and Tx of urinary retention
Neostigmine adverse
Hypotension Salivation, flushing Abdominal pain Nausea, diarrhea Bronchospasm
Physostigmine indications
Tx for anticholinergic overdose
Intestinal or bladder atony
Physostigmine adverse
High dose -> convulsions**, skeletal muscle paralysis, bradycardia
Contraindicated in suspected TCA overdose -> aggravates depression of cardiac conduction (TCA’s block sodium channels)
Edrophonium indication
Diagnosis of Myasthenia gravis (rapid increase in muscle strength after dose)
Reverse neuromuscular block produced by non depolarizing muscular blockers (can be used for recovery after surgery)
AChE inhibitor effects
CNS: convulsion, coma, respiratory arrest
PS action in the eye, respiratory, GI and urinary tracts
CVS: -ve chronotropic and inotropic effects -> decreased CO and hypotension
NMJ: increased contraction in weak muscles
Acetylcholine Receptor
N and M
Acetylcholine mechanism
Binding to M receptor induces PS activity
Nicotinic effects once M receptors are blocked by atropine (high dose)
Acetylcholine Effects
M: parasympathetic and sympathetic activity, sweat glands
CVS: M3 vasodilation and reflex tachycardia at small doses; hypotension and bradycardia at higher doses
N: stimulate all autonomic ganglia, secretion of Epi from adrenal medulla; skeletal muscle increase HR, BP, etc.
Acetylcholine indication/use
Small iv-> drop BP with tachycardia
Virtually no use except
Cataract surgery -> rapid miosis
Cholinergic agonist adverse
Muscarinic syndrome
Generalized cholinergic stimulation -> sweating, miosis, flushing, salivation, bradycardia, hypotension, bronchospasm
DUMBBELLSS-> Diarrhea Urination Miosis Bradycardia Bronchoconstriction Emesis Lacrimation Lethargy Salivation Sweating
Bethanechol receptor
M
Bethanechol mechanism
Parasympathetic
Bethanechol effects
Activates bowel and bladder
Bethanechol indication/use
Urinary retention (post-surgical postpartum) Hypotonic, myogenic, neurogenic bladder ... atony
Ileus, gastroparesis, congenital megacolon
Cannot cross BBB
Carbachol receptor
M and N
Carbachol mechanism
parasympathetic
Carbachol effects
Miosis and contraction of ciliaris muscle
Carbachol indication/use
Intraocular surgery
Glaucoma - decrease intraocular pressure (use pilocarpine first)
External use only
Methacholine receptor
M and little N
Methacholine indication/use
diagnosis of bronchial airway hyperreactivity in patients without clinically apparent asthma
Pilocarpine receptor
Partial M
tertiary amine
Pilocarpine effects
Contraction of ciliaris
Secretion from sweat, salivary, lacrimal and bronchial glands
Pilocarpine indication/use
Acute close-angle glaucoma
Open angle glaucoma -> 2nd line after timolol
Included in the regimen for close angle glaucoma with: timolol, apraclonidine, acetazolamide, and mannitol or glycerol
Pilocarpine adverse
CNS disturbances
Sweating
Salivation
Nicotine receptor
Nn>Nm
Tertiary amine
Nicotine mechanism/effect
Low dose: ganglion deploarization in both sympathetic and parasympathetic
CVS: sympathomimetic due to catecholamine release
GI and UG: parasympathomimetic -> n/v/d, voiding, salivary and bronchial secretions
High dose: ganglion blockade due to prolonged depolarization (desensitization)
Nicotine indication/use
smoking cessation therapy
Nicotine adverse
Acute nicotine poisoning: nausea, salivation, abdominal pain, vomiting, diarrhea, cold sweat, confusion, etc.
Hypotension with a rapid and weak pulse
Can lead to death respiratory arrest (central or peripheral)